KCNIP3 and early-onset autosomal dominant Alzheimer disease: The calcium-binding protein DREAM, from the recoverin family, functions as a calcium-regulated transcriptional repressor [65,66] and its modulation could have therapeutic potential for neurological diseases such as Alzheimer’s disease [67].